Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026)
Kestra Medical Technologies (KMTS) reported Cash from Investing Activities of -$14.9 million for Q1 2026, down 235.26% year-over-year from $11.0 million in Q1 2025, and down 101.06% quarter-over-quarter from -$7.4 million in Q4 2025.
Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has 3 years of Cash from Investing Activities data on file, last reported at -$14.9 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$14.9 million, down 235.26% year-over-year; the trailing twelve-month figure through Jan 2026 was -$38.0 million (down 89.28% YoY), and the FY2025 annual result was -$23.3 million, down 90.6% from the prior year.
- Cash from Investing Activities fell to -$14.9 million in Q1 2026 per KMTS's latest filing, from -$7.4 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$4.2 million in Q2 2024 and troughed at -$14.9 million in Q1 2026.
- A 3-year average of -$7.3 million and a median of -$7.2 million in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities decreased 17.03% in 2025, then slumped 235.26% in 2026.
- A 3-year view of Cash from Investing Activities shows it stood at -$4.4 million in 2024, then plunged by 67.87% to -$7.4 million in 2025, then plunged by 101.06% to -$14.9 million in 2026.
- Business Quant data shows KMTS's Cash from Investing Activities at -$14.9 million in Q1 2026, -$7.4 million in Q4 2025, and -$8.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Kestra Medical Technologies | 1.02 Bn | 732.25 Mn | 12.91 Mn | -14.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -14.92 Mn |
| Jan 31, 2026 | -14.92 Mn |
| Oct 31, 2025 | -7.42 Mn |
| Oct 31, 2025 | -7.42 Mn |
| Jul 31, 2025 | -8.23 Mn |
| Jul 31, 2025 | -8.23 Mn |
| Apr 30, 2025 | -7.40 Mn |
| Apr 30, 2025 | -7.40 Mn |
| Jan 31, 2025 | -4.45 Mn |
| Jan 31, 2025 | -4.45 Mn |
| Oct 31, 2024 | -4.42 Mn |
| Oct 31, 2024 | -4.42 Mn |
| Jul 31, 2024 | -7.03 Mn |
| Jul 31, 2024 | -7.03 Mn |
| Apr 30, 2024 | -4.16 Mn |
| Apr 30, 2024 | -4.16 Mn |